Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$845,340
-$107,532 QoQ
Shares Held
6,691
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,150
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $156,508,696 across 14 Drug Manufacturers - General names. GILD ranks #10 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
170,334 | $43,259,725 | |
| 2 | LLY |
ELI LILLY & Co
|
33,088 | $39,686,743 | |
| 3 | ABBV |
AbbVie Inc.
|
155,264 | $39,070,632 | |
| 4 | MRK |
Merck & Co., Inc.
|
96,505 | $12,400,892 | |
| 5 | AMGN |
Amgen Inc
|
23,570 | $8,535,168 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
93,509 | $5,387,988 | |
| 7 | PFE |
Pfizer Inc
|
100,100 | $2,410,408 | |
| 8 | NVS |
Novartis AG
|
12,976 | $2,033,598 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $845,340 | 6,691 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $952,872 | 6,837 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,548,119 | 12,613 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,530,246 | 13,786 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,579,786 | 14,249 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,354,460 | 12,088 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,536,020 | 16,629 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,264,307 | 15,080 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,292,397 | 33,412 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,429,775 | 33,171 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,737,651 | 33,794 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,428,655 | 32,408 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,586,083 | 33,555 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,794,180 | 33,677 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,650,275 | 30,871 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,914,549 | 31,035 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,903,006 | 30,788 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,437,025 | 24,172 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,898,243 | 26,143 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,652,930 | 23,664 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,671,920 | 24,280 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,585,503 | 24,532 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,433,778 | 24,610 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,600,476 | 25,328 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,951,736 | 25,367 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,850,534 | 24,753 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||